Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James K Breaux

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Methods in Molecular Medicine|May 25, 2005
Gene expression profiling to characterize anticancer drug sensitivityJames K Breaux, Gerrit Los
Cancer Chemotherapy and Pharmacology|June 14, 2006
Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatinGoli Samimi, Shuichi Kishimoto, Gerald Manorek, et al.
Cytometry|January 5, 2002
Using mRNA expression profiling to determine anticancer drug efficacyGerrit Los, Fei Yang, Goli Samimi, et al.
Cancer Chemotherapy and Pharmacology|September 21, 2004
cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistanceGoli Samimi, Gerald Manorek, Rob Castel, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Methods in Molecular Medicine|May 25, 2005
Gene expression profiling to characterize anticancer drug sensitivityJames K Breaux, Gerrit Los
Cancer Chemotherapy and Pharmacology|June 14, 2006
Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatinGoli Samimi, Shuichi Kishimoto, Gerald Manorek, et al.
Cytometry|January 5, 2002
Using mRNA expression profiling to determine anticancer drug efficacyGerrit Los, Fei Yang, Goli Samimi, et al.
Cancer Chemotherapy and Pharmacology|September 21, 2004
cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistanceGoli Samimi, Gerald Manorek, Rob Castel, et al.
Pageof 1